Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,131,959
-
Share change
-
+13,040,497
-
Total reported value
-
$36,976,249
-
Put/Call ratio
-
91%
-
Price per share
-
$1.75
-
Number of holders
-
86
-
Value change
-
+$22,179,404
-
Number of buys
-
64
-
Number of sells
-
17
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q1 2023
As of 31 Mar 2023,
Summit Therapeutics Inc. - COM (SMMT) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,131,959 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, AWM Investment Company, Inc., MORGAN STANLEY, Steward Partners Investment Advisory, LLC, and CSS LLC/IL.
This page lists
86
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.